{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:36:17Z","timestamp":1787675777716,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dalian Medical University Maternal Diseases on Newborns Interdisciplinary Research Cooperation Project Team Funding","award":["JCHZ2023016"],"award-info":[{"award-number":["JCHZ2023016"]}]},{"name":"A Real World Study on the Situation of Children\u2019s Medical Security in Liaoning Province Based on Interrupted Time Series Analysis","award":["LJKMR20221296"],"award-info":[{"award-number":["LJKMR20221296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder, leading to various complications and impairments in patients\u2019 health-related quality of life (HRQOL). Limited research has been conducted to evaluate the HRQOL of Chinese patients with PNH. Understanding the HRQOL in this specific population is crucial for providing effective healthcare interventions and improving patient\u2019 health outcomes. This study aimed to assess HRQOL of Chinese patients with PNH, and identify key determinants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted during 2022 to recruit patients with PNH in China. The study population was recruited from PNH China, one of the largest public welfare PNH patient mutual aid organization in China. Data were collected via an online questionnaire including the EQ-5D-5L (5L), and social-demographic and clinical characteristics. Descriptive statistics were employed to summarize the characteristics of the participants and their HRQOL. Multiple linear and logistic regression analyses were adopted to explore key factors affecting HRQOL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 329 valid questionnaires were collected. The mean (SD) age of the patients was 35.3 (10.0) years, with 52.3% of them being male. The patients reported more problems in Anxiety\/Depression (81.5%) and Pain\/Discomfort (69.9%) dimensions compared to the other three 5L dimensions. The mean (SD) of 5L health utility score (HUS) and EQ-VAS score were 0.76 (0.21) and 62.61 (19.20), respectively. According to multiple linear regression, initial symptoms (i.e., Anemia [fatigue, tachycardia, shortness of breath, headache] and back pain) and complication of thrombosis were significant influencing factors affecting 5L HUS. Total personal income of the past year, initial symptom of hemoglobinuria and complication of thrombosis were significantly influencing factors of VAS score. Social-demographic and clinical characteristics, such as gender, income, and thrombosis, were also found to be significantly related to certain 5L health problems as well.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study manifested the HRQOL of PNH patients in China was markedly compromised, especially in two mental-health related dimensions, and revealed several socio-demographic and clinical factors of their HRQOL. These findings could be used as empirical evidence for enhancing the HRQOL of PNH patients in China.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03178-x","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T09:02:43Z","timestamp":1714726963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Health-related quality of life and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China"],"prefix":"10.1186","volume":"19","author":[{"given":"Huaxin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niekun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"issue":"18","key":"3178_CR1","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014;124(18):2804\u201311. https:\/\/doi.org\/10.1182\/blood-2014-02-522128.","journal-title":"Blood"},{"key":"3178_CR2","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill A, DeZern AE, Kinoshita T, et al. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028. https:\/\/doi.org\/10.1038\/nrdp.2017.28. Published 2017 May 18.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 4","key":"3178_CR3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1002\/ajh.26832","volume":"98","author":"J Panse","year":"2023","unstructured":"Panse J. Paroxysmal nocturnal hemoglobinuria: where we stand. Am J Hematol. 2023;98(Suppl 4):S20\u201332. https:\/\/doi.org\/10.1002\/ajh.26832.","journal-title":"Am J Hematol"},{"issue":"6","key":"3178_CR4","doi-asserted-by":"publisher","first-page":"16271","DOI":"10.20452\/pamw.16271","volume":"132","author":"U Szlendak","year":"2022","unstructured":"Szlendak U, Budziszewska B, Spychalska J, et al. Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment. Pol Arch Intern Med. 2022;132(6):16271. https:\/\/doi.org\/10.20452\/pamw.16271.","journal-title":"Pol Arch Intern Med"},{"issue":"3","key":"3178_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.htct.2020.06.006","volume":"43","author":"RD Can\u00e7ado","year":"2021","unstructured":"Can\u00e7ado RD, Ara\u00fajo ADS, Sandes AF, et al. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematol Transfus Cell Ther. 2021;43(3):341\u20138. https:\/\/doi.org\/10.1016\/j.htct.2020.06.006.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"19","key":"3178_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333(19):1253\u20138. https:\/\/doi.org\/10.1056\/NEJM199511093331904.","journal-title":"N Engl J Med"},{"key":"3178_CR7","doi-asserted-by":"publisher","first-page":"204062071987472","DOI":"10.1177\/2040620719874728","volume":"10","author":"RM Stern","year":"2019","unstructured":"Stern RM, Connell NT. Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria. Ther Adv Hematol. 2019;10:2040620719874728. https:\/\/doi.org\/10.1177\/2040620719874728. Published 2019 Sep 10.","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"3178_CR8","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699\u2013709. https:\/\/doi.org\/10.1182\/blood-2005-04-1717.","journal-title":"Blood"},{"issue":"9","key":"3178_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/imj.13160","volume":"46","author":"G Soci\u00e9","year":"2016","unstructured":"Soci\u00e9 G, Schrezenmeier H, Muus P, et al. Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry. Intern Med J. 2016;46(9):1044\u201353. https:\/\/doi.org\/10.1111\/imj.13160.","journal-title":"Intern Med J"},{"issue":"6","key":"3178_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12185-016-1995-1","volume":"103","author":"F Yu","year":"2016","unstructured":"Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe\/America. Int J Hematol. 2016;103(6):649\u201354. https:\/\/doi.org\/10.1007\/s12185-016-1995-1.","journal-title":"Int J Hematol"},{"issue":"4","key":"3178_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ejh.12346","volume":"93","author":"C Mu\u00f1oz-Linares","year":"2014","unstructured":"Mu\u00f1oz-Linares C, Ojeda E, For\u00e9s R, et al. Paroxysmal nocturnal hemoglobinuria: a single Spanish center\u2019s experience over the last 40 year. Eur J Haematol. 2014;93(4):309\u201319. https:\/\/doi.org\/10.1111\/ejh.12346.","journal-title":"Eur J Haematol"},{"key":"3178_CR12","unstructured":"Guidelines for Diagnosis and Treatment of Rare Diseases in China. 2019;547\u2013554."},{"issue":"5","key":"3178_CR13","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier H, Muus P, Soci\u00e9 G, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99(5):922\u20139. https:\/\/doi.org\/10.3324\/haematol.2013.093161.","journal-title":"Haematologica"},{"issue":"7","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","volume":"99","author":"H Schrezenmeier","year":"2020","unstructured":"Schrezenmeier H, R\u00f6th A, Araten DJ, et al. Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. Ann Hematol. 2020;99(7):1505\u201314. https:\/\/doi.org\/10.1007\/s00277-020-04052-z.","journal-title":"Ann Hematol"},{"key":"3178_CR15","doi-asserted-by":"publisher","unstructured":"Gao Z, Wang P, Hong J et al. Health-related quality of life among Chinese patients with Crohn\u2019s disease: a cross-sectional survey using the EQ-5D-5L. Health Qual Life Outcomes. 2022;20(1):62. Published 2022 Apr 12. https:\/\/doi.org\/10.1186\/s12955-022-01969-z.","DOI":"10.1186\/s12955-022-01969-z"},{"key":"3178_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi M, Brazier J. Health, Health-Related Quality of Life, and quality of life: what is the difference? PharmacoEconomics. 2016;34:645\u20139. https:\/\/doi.org\/10.1007\/s40273-016-0389-9.","journal-title":"PharmacoEconomics"},{"key":"3178_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12963-016-0091-3","volume":"14","author":"S Yin","year":"2016","unstructured":"Yin S, Njai R, Barker L, et al. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metrics. 2016;14:22. https:\/\/doi.org\/10.1186\/s12963-016-0091-3.","journal-title":"Popul Health Metrics"},{"issue":"1 Suppl 1","key":"3178_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.seminhematol.2008.11.004","volume":"46","author":"NS Young","year":"2009","unstructured":"Young NS, Meyers G, Schrezenmeier H, et al. The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. Semin Hematol. 2009;46(1 Suppl 1):S1\u201316. https:\/\/doi.org\/10.1053\/j.seminhematol.2008.11.004.","journal-title":"Semin Hematol"},{"issue":"4","key":"3178_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/ejh.13816","volume":"109","author":"J Panse","year":"2022","unstructured":"Panse J, Sicre de Fontbrune F, Burmester P, et al. The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: patient-reported insights on symptoms and quality of life. Eur J Haematol. 2022;109(4):351\u201363. https:\/\/doi.org\/10.1111\/ejh.13816.","journal-title":"Eur J Haematol"},{"issue":"9","key":"3178_CR20","doi-asserted-by":"publisher","first-page":"e0237497","DOI":"10.1371\/journal.pone.0237497","volume":"15","author":"JD Peipert","year":"2020","unstructured":"Peipert JD, Kulasekararaj AG, Gaya A, et al. Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS ONE. 2020;15(9):e0237497. https:\/\/doi.org\/10.1371\/journal.pone.0237497. Published 2020 Sep 4.","journal-title":"PLoS ONE"},{"key":"3178_CR21","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1182\/blood-2022-163821","volume":"140","author":"D Desai","year":"2022","unstructured":"Desai D, Hadker N, Francis A, et al. Health-Related Quality of Life reported among patients with Paroxysmal Nocturnal Hemoglobinuria: impact of treatment with Pegcetacoplan and C5-Inhibitors. Blood. 2022;140:11445\u201346. https:\/\/doi.org\/10.1182\/blood-2022-163821.","journal-title":"Blood"},{"issue":"9","key":"3178_CR22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s10198-022-01556-5","volume":"24","author":"SW Quist","year":"2023","unstructured":"Quist SW, Postma AJ, Myr\u00e9n KJ, et al. Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands. Eur J Health Econ. 2023;24(9):1455\u201372. https:\/\/doi.org\/10.1007\/s10198-022-01556-5.","journal-title":"Eur J Health Econ"},{"key":"3178_CR23","doi-asserted-by":"publisher","first-page":"675523","DOI":"10.3389\/fpubh.2021.675523","volume":"9","author":"T Zhou","year":"2021","unstructured":"Zhou T, Guan H, Wang L, et al. Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: a systematic review. Front Public Health. 2021;9:675523. https:\/\/doi.org\/10.3389\/fpubh.2021.675523. Published 2021 Jun 29.","journal-title":"Front Public Health"},{"issue":"6","key":"3178_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40273-020-00893-8","volume":"38","author":"AJ Thompson","year":"2020","unstructured":"Thompson AJ, Turner AJ. A comparison of the EQ-5D-3L and EQ-5D-5L. PharmacoEconomics. 2020;38(6):575\u201391. https:\/\/doi.org\/10.1007\/s40273-020-00893-8.","journal-title":"PharmacoEconomics"},{"issue":"4","key":"3178_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10198-021-01279-z","volume":"22","author":"ASJ Christiansen","year":"2021","unstructured":"Christiansen ASJ, M\u00f8ller MLS, Kronborg C, et al. Comparison of the three-level and the five-level versions of the EQ-5D. Eur J Health Econ. 2021;22(4):621\u20138. https:\/\/doi.org\/10.1007\/s10198-021-01279-z.","journal-title":"Eur J Health Econ"},{"issue":"6","key":"3178_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10198-022-01523-0","volume":"24","author":"CW Pan","year":"2023","unstructured":"Pan CW, He JY, Zhu YB, et al. Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. Eur J Health Econ. 2023;24(6):885\u201393. https:\/\/doi.org\/10.1007\/s10198-022-01523-0.","journal-title":"Eur J Health Econ"},{"issue":"5","key":"3178_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12603-016-0784-0","volume":"21","author":"CW Pan","year":"2017","unstructured":"Pan CW, Ma Q, Sun HP, et al. Tea consumption and health-related quality of life in older adults. J Nutr Health Aging. 2017;21(5):480\u20136. https:\/\/doi.org\/10.1007\/s12603-016-0784-0.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"3178_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, et al. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662\u20139. https:\/\/doi.org\/10.1016\/j.jval.2016.11.016.","journal-title":"Value Health"},{"key":"3178_CR29","unstructured":"Statistical Bulletin of the People\u2019s Republic of China on National Economic and Social Development in 2021. China Stat. 2022;(03):9\u201326."},{"issue":"1","key":"3178_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","volume":"126","author":"VM Moyo","year":"2004","unstructured":"Moyo VM, Mukhina GL, Garrett ES, et al. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126(1):133\u20138. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04992.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"3178_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00277-012-1413-6","volume":"91","author":"M Ge","year":"2012","unstructured":"Ge M, Li X, Shi J, et al. Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China. Ann Hematol. 2012;91(7):1121\u20138. https:\/\/doi.org\/10.1007\/s00277-012-1413-6.","journal-title":"Ann Hematol"},{"issue":"1","key":"3178_CR32","doi-asserted-by":"publisher","first-page":"e23008","DOI":"10.1002\/jcla.23008","volume":"34","author":"R Fu","year":"2020","unstructured":"Fu R, Li L, Li L, et al. Analysis of clinical characteristics of 92 patients with paroxysmal nocturnal hemoglobinuria: a single institution experience in China. J Clin Lab Anal. 2020;34(1):e23008. https:\/\/doi.org\/10.1002\/jcla.23008.","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"3178_CR33","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1007\/s12325-021-01825-4","volume":"38","author":"WY Cheng","year":"2021","unstructured":"Cheng WY, Sarda SP, Mody-Patel N, et al. Real-world Healthcare Resource utilization (HRU) and costs of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) receiving Eculizumab in a US Population. Adv Ther. 2021;38(8):4461\u201379. https:\/\/doi.org\/10.1007\/s12325-021-01825-4.","journal-title":"Adv Ther"},{"issue":"12\u2013b Suppl","key":"3178_CR34","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.18553\/jmcp.2020.26.12-b.s14","volume":"26","author":"M Bektas","year":"2020","unstructured":"Bektas M, Copley-Merriman C, Khan S, et al. Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs. J Manag Care Spec Pharm. 2020;26(12\u2013b Suppl):S14\u201320. https:\/\/doi.org\/10.18553\/jmcp.2020.26.12-b.s14.","journal-title":"J Manag Care Spec Pharm"},{"issue":"12\u2013b Suppl","key":"3178_CR35","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.18553\/jmcp.2020.26.12-b.s8","volume":"26","author":"M Bektas","year":"2020","unstructured":"Bektas M, Copley-Merriman C, Khan S, et al. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. J Manag Care Spec Pharm. 2020;26(12\u2013b Suppl):S8\u201314. https:\/\/doi.org\/10.18553\/jmcp.2020.26.12-b.s8.","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"3178_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3346\/jkms.2016.31.2.214","volume":"31","author":"JH Jang","year":"2016","unstructured":"Jang JH, Kim JS, Yoon SS, et al. Predictive factors of Mortality in Population of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): results from a Korean PNH Registry. J Korean Med Sci. 2016;31(2):214\u201321. https:\/\/doi.org\/10.3346\/jkms.2016.31.2.214.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3178_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.13059","volume":"101","author":"A R\u00f6th","year":"2018","unstructured":"R\u00f6th A, Maciejewski J, Nishimura JI, et al. Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus. Eur J Haematol. 2018;101(1):3\u201311. https:\/\/doi.org\/10.1111\/ejh.13059.","journal-title":"Eur J Haematol"},{"issue":"10","key":"3178_CR38","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood.2019003812","volume":"137","author":"RA Brodsky","year":"2021","unstructured":"Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2021;137(10):1304\u20139. https:\/\/doi.org\/10.1182\/blood.2019003812.","journal-title":"Blood"},{"issue":"8","key":"3178_CR39","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099\u2013106. https:\/\/doi.org\/10.1182\/blood-2008-01-133918.","journal-title":"Blood"},{"key":"3178_CR40","first-page":"205","volume":"95","author":"JW Lee","year":"2010","unstructured":"Lee JW, Jang JH, Lee JH, HIGH PREVALENCE AND MORTALITY ASSOCIATED WITH THROMBOEMBOLISM IN ASIAN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), et al. HAEMATOLOGICA-THE Hematol J. 2010;95:205\u201306.","journal-title":"HAEMATOLOGICA-THE Hematol J"},{"issue":"6","key":"3178_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12185-013-1346-4","volume":"97","author":"JW Lee","year":"2013","unstructured":"Lee JW, Jang JH, Kim JS, et al. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Int J Hematol. 2013;97(6):749\u201357. https:\/\/doi.org\/10.1007\/s12185-013-1346-4.","journal-title":"Int J Hematol"},{"issue":"26","key":"3178_CR42","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.1182\/blood-2009-03-195966","volume":"113","author":"RA Brodsky","year":"2009","unstructured":"Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2009;113(26):6522\u20137. https:\/\/doi.org\/10.1182\/blood-2009-03-195966.","journal-title":"Blood"},{"issue":"5","key":"3178_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/bjh.16473","volume":"189","author":"L Luzzatto","year":"2020","unstructured":"Luzzatto L. PNH phenotypes and their genesis. Br J Haematol. 2020;189(5):802\u20135. https:\/\/doi.org\/10.1111\/bjh.16473.","journal-title":"Br J Haematol"},{"key":"3178_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","volume":"686","author":"B Gulbis","year":"2010","unstructured":"Gulbis B, Eleftheriou A, Angastiniotis M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375\u201396. https:\/\/doi.org\/10.1007\/978-90-481-9485-8_22.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"3178_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","volume":"149","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Wang X, et al. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2010;149(3):414\u201325. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08096.x.","journal-title":"Br J Haematol"},{"key":"3178_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcmd.2017.03.013","volume":"65","author":"MN Yenerel","year":"2017","unstructured":"Yenerel MN, Muus P, Wilson A, et al. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status. Blood Cells Mol Dis. 2017;65:29\u201334. https:\/\/doi.org\/10.1016\/j.bcmd.2017.03.013.","journal-title":"Blood Cells Mol Dis"},{"key":"3178_CR47","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1182\/blood-2022-167531","volume":"140","author":"A Waheed","year":"2022","unstructured":"Waheed A, Kaufhold S, Liu C-R, et al. A systematic literature review of clinical and economic outcomes for patients with paroxysmal nocturnal hemoglobinuria in clinical trials and real-world settings. Blood. 2022;140:11451\u201352. https:\/\/doi.org\/10.1182\/blood-2022-167531.","journal-title":"Blood"},{"issue":"9","key":"3178_CR48","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00277-022-04887-8","volume":"101","author":"D Cella","year":"2022","unstructured":"Cella D, Sarda SP, Hsieh R, et al. Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study. Ann Hematol. 2022;101(9):1905\u201314. https:\/\/doi.org\/10.1007\/s00277-022-04887-8.","journal-title":"Ann Hematol"},{"key":"3178_CR49","doi-asserted-by":"publisher","first-page":"1128994","DOI":"10.3389\/fonc.2023.1128994","volume":"13","author":"S Chatzileontiadou","year":"2023","unstructured":"Chatzileontiadou S, Hatjiharissi E, Angelopoulou M, et al. Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): real world data of a Greek nationwide multicenter retrospective study. Front Oncol. 2023;13:1128994. https:\/\/doi.org\/10.3389\/fonc.2023.1128994. Published 2023 Mar 7.","journal-title":"Front Oncol"},{"issue":"08","key":"3178_CR50","first-page":"631","volume":"8","author":"TQ Zhang","year":"2020","unstructured":"Zhang TQ, Wu HY, Cai YF, et al. Researches on the Status of Life Quality of Chinese Population and its influencing factors based on EQ-5D-5L and SF-6D scales. Chin Health Service Manage. 2020;8(08):631\u20134.","journal-title":"Chin Health Service Manage"},{"key":"3178_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/JBM.S339660","volume":"13","author":"B Fattizzo","year":"2022","unstructured":"Fattizzo B, Cavallaro F, Oliva EN, et al. Managing fatigue in patients with Paroxysmal Nocturnal Hemoglobinuria: a patient-focused perspective. J Blood Med. 2022;13:327\u201335. https:\/\/doi.org\/10.2147\/JBM.S339660. Published 2022 Jun 17.","journal-title":"J Blood Med"},{"key":"3178_CR52","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1186\/1471-2458-14-1310","volume":"14","author":"F Norstr\u00f6m","year":"2014","unstructured":"Norstr\u00f6m F, Virtanen P, Hammarstr\u00f6m A, et al. How does unemployment affect self-assessed health? A systematic review focusing on subgroup effects. BMC Public Health. 2014;14:1310. https:\/\/doi.org\/10.1186\/1471-2458-14-1310. Published 2014 Dec 22.","journal-title":"BMC Public Health"},{"issue":"8","key":"3178_CR53","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1377\/hlthaff.2015.1357","volume":"35","author":"RL Thornton","year":"2016","unstructured":"Thornton RL, Glover CM, Cen\u00e9 CW, et al. Evaluating strategies for reducing Health disparities by addressing the Social Determinants of Health. Health Aff (Millwood). 2016;35(8):1416\u201323. https:\/\/doi.org\/10.1377\/hlthaff.2015.1357.","journal-title":"Health Aff (Millwood)"},{"key":"3178_CR54","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-publhealth-031210-101218","volume":"32","author":"P Braveman","year":"2011","unstructured":"Braveman P, Egerter S, Williams DR. The social determinants of health: coming of age. Annu Rev Public Health. 2011;32:381\u201398. https:\/\/doi.org\/10.1146\/annurev-publhealth-031210-101218.","journal-title":"Annu Rev Public Health"},{"issue":"12","key":"3178_CR55","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.2337\/diacare.27.12.2980","volume":"27","author":"S Kim","year":"2004","unstructured":"Kim S, Love F, Quistberg DA, et al. Association of health literacy with self-management behavior in patients with diabetes. Diabetes Care. 2004;27(12):2980\u20132. https:\/\/doi.org\/10.2337\/diacare.27.12.2980.","journal-title":"Diabetes Care"},{"issue":"3","key":"3178_CR56","first-page":"838","volume":"8","author":"PK Rani","year":"2008","unstructured":"Rani PK, Raman R, Subramani S, et al. Knowledge of diabetes and diabetic retinopathy among rural populations in India, and the influence of knowledge of diabetic retinopathy on attitude and practice. Rural Remote Health. 2008;8(3):838.","journal-title":"Rural Remote Health"},{"issue":"4","key":"3178_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.phrp.2014.06.004","volume":"5","author":"PF Lemes Dos Santos","year":"2014","unstructured":"Lemes Dos Santos PF, Dos Santos PR, Ferrari GS, et al. Knowledge of diabetes mellitus: does gender make a difference? Osong Public Health Res Perspect. 2014;5(4):199\u2013203. https:\/\/doi.org\/10.1016\/j.phrp.2014.06.004.","journal-title":"Osong Public Health Res Perspect"},{"issue":"13","key":"3178_CR58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653\u201362. https:\/\/doi.org\/10.1001\/jama.293.13.1653.","journal-title":"JAMA"},{"issue":"3","key":"3178_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1445-5994.2012.02924.x","volume":"43","author":"I Weitz","year":"2013","unstructured":"Weitz I, Meyers G, Lamy T, et al. Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria. Intern Med J. 2013;43(3):298\u2013307. https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02924.x.","journal-title":"Intern Med J"},{"issue":"S7","key":"3178_CR60","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.5694\/j.1326-5377.2009.tb02471.x","volume":"190","author":"DM Clarke","year":"2009","unstructured":"Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009;190(S7):S54\u201360. https:\/\/doi.org\/10.5694\/j.1326-5377.2009.tb02471.x.","journal-title":"Med J Aust"},{"issue":"1","key":"3178_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejpain.2004.02.006","volume":"9","author":"IE Lam\u00e9","year":"2005","unstructured":"Lam\u00e9 IE, Peters ML, Vlaeyen JW, et al. Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. Eur J Pain. 2005;9(1):15\u201324. https:\/\/doi.org\/10.1016\/j.ejpain.2004.02.006.","journal-title":"Eur J Pain"},{"issue":"2","key":"3178_CR62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/cam4.1953","volume":"8","author":"CP Escalante","year":"2019","unstructured":"Escalante CP, Chisolm S, Song J, et al. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. Cancer Med. 2019;8(2):543\u201353. https:\/\/doi.org\/10.1002\/cam4.1953.","journal-title":"Cancer Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T09:13:29Z","timestamp":1714727609000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03178-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"1 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Biomedical Ethics Committee of Dalian Medical University. Informed consent has been obtained of all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}